BlackRock Institutional Trust’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

BlackRock Institutional Trust’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$25.8M	Buy	1,716,754 +80,475	+5%	+$1.06M	﹤0.01%	1787
2016 Q3	$19.1M	Buy	1,636,279 +24,978	+2%	+$294K	﹤0.01%	1926
2016 Q2	$17.4M	Sell	1,611,301 -93,186	-5%	-$961K	﹤0.01%	1938
2016 Q1	$15.7M	Sell	1,704,487 -64,525	-4%	-$694K	﹤0.01%	1972
2015 Q4	$26.3M	Buy	1,769,012 +99,129	+6%	+$1.66M	﹤0.01%	1671
2015 Q3	$27.4M	Buy	1,669,883 +82,963	+5%	+$1.7M	﹤0.01%	1611
2015 Q2	$36.2M	Buy	1,586,920 +32,365	+2%	+$645K	0.01%	1502
2015 Q1	$23.6M	Buy	1,554,555 +8,361	+0.5%	+$109K	﹤0.01%	1827
2014 Q4	$18.6M	Sell	1,546,194 -64,351	-4%	-$735K	﹤0.01%	1961
2014 Q3	$18.3M	Sell	1,610,545 -27,397	-2%	-$312K	﹤0.01%	1928
2014 Q2	$19.8M	Buy	1,637,942 +165,959	+11%	+$1.96M	﹤0.01%	1966
2014 Q1	$17.1M	Buy	1,471,983 +70,498	+5%	+$1.19M	﹤0.01%	2073
2013 Q4	$24.8M	Sell	1,401,485 -23,410	-2%	-$393K	﹤0.01%	1787
2013 Q3	$20.5M	Buy	1,424,895 +25,689	+2%	+$393K	﹤0.01%	1840
2013 Q2	$21.1M	Buy	+1,399,206	New	+$18.5M	﹤0.01%	1777

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock Institutional Trust's MNTA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 4.9% in Q4 2016, buying an estimated $1.06M and bringing the position to 1,716,754 shares worth $25.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

BlackRock Institutional Trust first reported a position in MNTA in Q2 2013 and has held it in 15 quarters since. The position peaked at $36.2M in Q2 2015. 160 funds tracked by Wall St. Rank hold MNTA as of Q4 2016.

BlackRock Institutional Trust held 1,716,754 shares of Momenta Pharmaceuticals, Inc. worth $25.8M as of Q4 2016.
BlackRock Institutional Trust bought 80,475 Momenta Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.06M.
Momenta Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1787 holding.
BlackRock Institutional Trust first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Momenta Pharmaceuticals, Inc. position peaked at $36.2M in Q2 2015.
160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.